Rachael Zimlich, RN, BSN

More than half of all family physicians report some level of burnout, and only a third say they are happy in their work.

Prior authorizations are time-consuming and frustrating. Find out how you can reduce the burden in your practice.

H1N1 is the most prevalent flu virus circulating this year, resulting in a less severe flu season overall than last year when H3N2 was predominant.

A new report links early treatment of influenza A/H3N2 with the drug to a 30% decrease in mortality.

Researchers have found that the microbiome in the respiratory tract contributes to how susceptible we each are to the flu. Work is underway to use this data to create a preventive tool

A new study reveals that llama antibodies may be effective in offering protection against numerous flu strains in a single vaccine

A new report highlights how flu vaccination rates decline as the day progresses, and how primary care practices can use ‘nudges’ to modify patient care behaviors.

A new vaccine in development could provide increased flu protection for seniors.

It’s too early yet to say whether last year’s devastating flu season will motivate more patients to receive flu shots, but so far it looks like a good year for the vaccine.

NasoVax is still in the development stages but may eventually provide an option for patients who are immunocompromised.

A new one-dose antiviral-the first treatment approved to fight the flu in 20 years-will be available to clinicians this flu season.

New tools to study the norovirus may lead to vaccines or even immunotherapy.

Report highlights physician preparedness, barriers for following pneumococcal vaccine guidance

Adult vaccination rates in the U.S. are low, and a new study offers insight on the consequences of missed vaccinations and how to close the gap.

The intranasal vaccine is back, and changes have been made to the viral composition of this year’s vaccine.

Pharmacies are a convenient option for patients who need vaccines, but there are still barriers that complicate the pharmacy-based vaccination process. A new report highlights the problems and proposes solutions.

Most practices aren’t aware of the many options for payment and reimbursement available for adult vaccines, according to a new report.

College students who never received the HPV vaccine series are interested in getting the shot on campus, according to a new study. The study is a reminder, according to the authors, to physicians that it’s never too late to offer the series to young adults.

A new study reveals that different compounds can impact the function of the body’s natural killer cells and provide clinicians with new tools in fighting cancer.

A new study details the use of bacteria to prevent PTSD, and possibly offer treatment for other stress disorders.

A new study reveals vaccine that could fight, prevent some cancers

The highly effective new shingles vaccine, Shingrix, has been in high demand since its launch in late 2017, but there have been supply issues and some administration errors. Find out what is being done.

Irregular visits and individualized needs can make it difficult for clinicians to help keep adult patients up-to-date on immunizations. Find out what you can do to keep your patients covered.

One of only four other HIV vaccines ever tested in human, the new “Mosaic” vaccine shows promise and is planned for be trialed by more than 2,500 high-risk women in the coming years.

Researchers across the world have been studying a century-old vaccine used primarily for tuberculosis treatment as a way to manage autoimmune conditions like Type 1 diabetes. New research is promising, and researchers are moving forward with a new, larger clinical trial.

There are many vaccines in development to fight Ebola, but few have been shown to have longevity-until now.

Vaccine hesitancy isn’t as much about additives, side effects, or organic parenting as it is about shifting societal trends toward distrust of medicine and a focus on one’s individual health, according to a new report.

Immune cells that previously were only known to play a role in harmful autoimmune processes may actually be useful in fighting hard-to-detect infections, according to a report.

Immunity wanes within a decade in 10 percent of patients vaccinated against pertussis.

A move to allow pharmacists to administer more vaccines could have a profound effect on adult vaccination rates and vaccine-preventable disease prevalence.